AFIB guidelines icon

Atrial Fibrillation (Management of)

ESC Clinical Practice Guidelines

Topics:

Atrial Fibrillation

Current versions available to download

Publication dateVersionsReferencesSize
2006Full TextEuropace 2006;8:651-745 doi:10.1093/europace/eul0972 MB
2006Executive SummaryEHJ 2006;27:1979–20302 MB
 Pocket guidelines
 PdaDownload the PDA version
 Slideset5 MB

Current translated versions available to download:

Authors

Valentin Fuster , Co-Chair; Lars E. Ryden, Co-Chair; David S. Cannom, Harry J. Crijns, Anne B. Curtis, Kenneth A. Ellenbogen, Jonathan L. Halperin, Jean-Yves Le Heuzey, G. Neal Kay, James E. Lowe, S. Bertil Olsson, Eric N. Prystowsky, Juan Luis Tamargo, Samuel Wann.

Endorsed by:

Table of contents: Full Text (ESC Clinical Practice Guidelines)

Definition

Atrial fibrillation, Related arrhythmias

Epidemiology and prognosis

Prevalence, Incidence, Prognosis

Pathophysiological mechanisms

  • Atrial factors 
  • Atrioventricular conduction
  • Myocardial and hemodynamic consequences of atrial fibrillation
  • Thromboembolism

Causes, associated conditions, clinical manifestations, and quality of life

Clinical evaluation

  • Basic evaluation of the patient with atrial fibrillation
  • Additional investigation of selected patients with atrial fibrillation

Management

Pharmacological and nonpharmacological therapeutic options:

  • Pharmacological therapy
  • Heart rate control versus rhythm control
  • Rate control during atrial fibrillation
  • Preventing thromboembolism
  • Cardioversion of atrial fibrillation
  • Pharmacological agents to maintain sinus rhythm 
  • Out-of-hospital initiation of antiarrhythmic drugs in patients with atrial fibrillation
  • Drugs under development

Direct-current cardioversion of atrial fibrillation and flutter:

  • Terminology
  • Technical aspects
  • Procedural aspects
  • Direct-current cardioversion in patients with implanted pacemakers and defibrillators
  • Risks and complications of directcurrent cardioversion of atrial fibrillation
  • Pharmacological enhancement of direct-current cardioversion
  • Prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion

Maintenance of sinus rhythm:

  • Pharmacological therapy
  • General approach to antiarrhythmic drug therapy
  • Selection of antiarrhythmic agents in patients with cardiac diseases
  • Nonpharmacological therapy for atrial fibrillation
  • Suppression of atrial fibrillation through pacing

Special considerations:

  • Postoperative AF
  • Acute myocardial infarction
  • Wolff-Parkinson-White (WPW) preexcitation syndromes
  • Hyperthyroidism
  • Pregnancy
  • Hypertrophic cardiomyopathy
  • Pulmonary diseases
  • Primary prevention

Proposed management strategies

Overview of algorithms for management of patients with atrial fibrillation:

  • Newly discovered atrial fibrillation
  • Recurrent paroxysmal atrial fibrillation
  • Recurrent persistent atrial fibrillation
  • Permanent atrial fibrillation

Previous versions

2006: Corrigendum to ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation:Full TextExecutive Summary 

2001:Euro Heart Journal 2001; 22, 1852–1923: Atrial Fibrillation (Management of):
 Full text | Executive Summary

A complete list of ESC Clinical Practice Guidelines (current and previous versions) endorsed by ESC National Society Members is available here